glycine has been researched along with Ovarian Neoplasms in 14 studies
Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Here, the natural product betulinic acid (BA) and chemical drug lonidamine (LN) were used as chemosensitizers in combination with doxorubicin (DOX) for ovarian cancer treatment." | 1.51 | Doxorubicin combined with betulinic acid or lonidamine in RGD ligand-targeted pH-sensitive micellar system for ovarian cancer treatment. ( Jin, X; Lv, H; Zhang, Z; Zhou, J, 2019) |
| "Proliferation of OVCAR3 and A2780 ovarian cancer cells was determined by methyl thiazolyl tetrazolium (MTT) assay, cell cycles and apoptosis and index of proliferation were detected by flow cytometry method." | 1.36 | [Expression of Notch3 and Notch intracellular domain in ovarian carcinoma and effect of N-[N-(3,5-difluorophenyl) acetyl-L-alanyl]-S-phenyl glycine t-butyl ester on ovarian carcinoma cell]. ( Liao, QP; Ma, K; Wen, HW, 2010) |
| "Choline was detected in 10/12 primary tumors and 5/11 metastatic lesions (range 2." | 1.35 | Metabolic characterization of primary and metastatic ovarian cancer by 1H-MRS in vivo at 3T. ( Brenton, JD; Crawford, R; Earl, H; Griffiths, JR; Joubert, I; Kataoka, MY; Lomas, DJ; McLean, MA; Priest, AN; Sala, E, 2009) |
| " To test these hypotheses, we determined the bioavailability of folate in serum and in ascitic/cystic fluids of ovarian carcinoma patients (n = 36)." | 1.30 | Homocysteine accumulation in human ovarian carcinoma ascitic/cystic fluids possibly caused by metabolic alteration of the methionine cycle in ovarian carcinoma cells. ( Boiocchi, M; Corona, G; Donada, C; Fabris, M; Toffoli, G; Viel, A; Zarrelli, A, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (28.57) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Eroglu, EC | 1 |
| Kucukgoz Gulec, U | 1 |
| Vardar, MA | 1 |
| Paydas, S | 1 |
| Jin, X | 1 |
| Zhou, J | 1 |
| Zhang, Z | 1 |
| Lv, H | 1 |
| Lancien, M | 1 |
| Gueno, L | 1 |
| Salle, S | 1 |
| Merieau, E | 1 |
| Beriou, G | 1 |
| Nguyen, TH | 1 |
| Abidi, A | 1 |
| Dilek, N | 1 |
| Solomon, P | 1 |
| Poschmann, J | 1 |
| Michielin, O | 1 |
| Vuillefroy de Silly, R | 1 |
| Vanhove, B | 1 |
| Louvet, C | 1 |
| Varmira, K | 1 |
| Hosseinimehr, SJ | 1 |
| Noaparast, Z | 1 |
| Abedi, SM | 1 |
| Sinharay, S | 1 |
| Randtke, EA | 1 |
| Jones, KM | 1 |
| Howison, CM | 1 |
| Chambers, SK | 1 |
| Kobayashi, H | 1 |
| Pagel, MD | 1 |
| McLean, MA | 1 |
| Priest, AN | 1 |
| Joubert, I | 1 |
| Lomas, DJ | 1 |
| Kataoka, MY | 1 |
| Earl, H | 1 |
| Crawford, R | 1 |
| Brenton, JD | 1 |
| Griffiths, JR | 1 |
| Sala, E | 1 |
| Ma, K | 1 |
| Wen, HW | 1 |
| Liao, QP | 1 |
| Yokoyama, Y | 1 |
| Ramakrishnan, S | 1 |
| Corona, G | 1 |
| Toffoli, G | 1 |
| Fabris, M | 1 |
| Viel, A | 1 |
| Zarrelli, A | 1 |
| Donada, C | 1 |
| Boiocchi, M | 1 |
| Kievit, E | 1 |
| van Gog, FB | 1 |
| Schlüper, HM | 1 |
| van Dongen, GA | 1 |
| Pinedo, HM | 1 |
| Boven, E | 1 |
| Kondrat'eva, NA | 1 |
| Dobrynin, IaV | 1 |
| Merkulov, MF | 1 |
| Ardelt, W | 1 |
| Vortel, V | 1 |
| Peychl, L | 1 |
| Skoda, V | 1 |
| Elis, J | 1 |
| Jandová, A | 1 |
| Laurová, L | 1 |
| Novotná, J | 1 |
| Perlík, F | 1 |
14 other studies available for glycine and Ovarian Neoplasms
| Article | Year |
|---|---|
GC-MS based metabolite fingerprinting of serous ovarian carcinoma and benign ovarian tumor.
Topics: Benzoic Acid; Biomarkers; Creatinine; Female; Gas Chromatography-Mass Spectrometry; Glutathione; Gly | 2022 |
Doxorubicin combined with betulinic acid or lonidamine in RGD ligand-targeted pH-sensitive micellar system for ovarian cancer treatment.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Arginine; Aspartic Acid; Betulinic Acid; Ce | 2019 |
Cystathionine-gamma-lyase overexpression in T cells enhances antitumor effect independently of cysteine autonomy.
Topics: Adoptive Transfer; Animals; CD8-Positive T-Lymphocytes; Cell Engineering; Cell Line, Tumor; Cell Pro | 2021 |
An improved radiolabelled RNA aptamer molecule for HER2 imaging in cancers.
Topics: Animals; Aptamers, Nucleotide; Cell Line, Tumor; Female; Glycine; Humans; Hydrazines; Indicators and | 2014 |
Noninvasive detection of enzyme activity in tumor models of human ovarian cancer using catalyCEST MRI.
Topics: Animals; Catalysis; Cell Line, Tumor; Contrast Media; Cysteine; Disease Models, Animal; Female; Fluo | 2017 |
Metabolic characterization of primary and metastatic ovarian cancer by 1H-MRS in vivo at 3T.
Topics: Aged; Algorithms; Biomarkers, Tumor; Choline; Female; Glycine; Humans; Magnetic Resonance Spectrosco | 2009 |
[Expression of Notch3 and Notch intracellular domain in ovarian carcinoma and effect of N-[N-(3,5-difluorophenyl) acetyl-L-alanyl]-S-phenyl glycine t-butyl ester on ovarian carcinoma cell].
Topics: Amyloid Precursor Protein Secretases; Apoptosis; Cell Line, Tumor; Glycine; Humans; Ovarian Neoplasm | 2010 |
Addition of an aminopeptidase N-binding sequence to human endostatin improves inhibition of ovarian carcinoma growth.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Arginine; Asparagine; CD13 Antigens; Cell L | 2005 |
Homocysteine accumulation in human ovarian carcinoma ascitic/cystic fluids possibly caused by metabolic alteration of the methionine cycle in ovarian carcinoma cells.
Topics: Adult; Aged; Ascitic Fluid; Cysteine; Female; Folic Acid; Glycine; Homocysteine; Humans; Methionine; | 1997 |
[186Re]-labeled mouse and chimeric monoclonal antibody 323/A3: a comparison of the efficacy in experimental human ovarian cancer.
Topics: Animals; Antibodies, Monoclonal; Chelating Agents; Combined Modality Therapy; Dose-Response Relation | 1998 |
[Biological properties of L-asparaginase preparations from E. coli in cell cultures].
Topics: Asparaginase; Burkitt Lymphoma; Cell Line; DNA, Neoplasm; Drug Evaluation, Preclinical; Drug Stabili | 1978 |
[Studies on the clinical significance of glycyl-L-leucine dipeptidase in blood platelets].
Topics: Adult; Age Factors; Aprotinin; Blood Platelets; Blood Preservation; Carcinoma; Contraceptives, Oral; | 1972 |
[2 cases of acquired latent focal toxoplasmosis of the brain in a cytostatic and corticosteroid treated neoplastic disease].
Topics: Autopsy; Brain; Brain Diseases; Busulfan; Female; Focal Infection; Glycine; Humans; Leukemia, Myeloi | 1970 |
Comparison of effects of cyclophosphamide, Cytembena, and Ypenyl in the treatment of inoperable ovarian carcinoma.
Topics: Acrylates; Antineoplastic Agents; Benzoates; Blood Cell Count; Blood Platelets; Bromine; Cyclophosph | 1971 |